Clinical trial
A Multi-Center, Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Study to Determine the Safety of PEP005 0.0025%, 0.01% and 0.05% Gel With Two Treatment Schedules, Day 1 & 2 or Day 1 & 8 Applications to Superficial Basal Cell Carcinoma
NCT00108134 is registered in ClinicalTrials.gov with Peplin as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Center, Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Study to Determine the Safety of PEP005 0.0025%, 0.01% and 0.05% Gel With Two Treatment Schedules, Day 1 & 2 or Day 1 & 8 Applications to Superficial Basal Cell Carcinoma
- Lead sponsor
- Peplin
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 31, 2005
- Completion date
- March 31, 2006
- Enrollment
- 60
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.